Cardiac Imaging Advantage HARP is FDA cleared for tagged MR images and forms the core of Diagnosoft's end to end cardiac MR analysis solution. This regulatory clearance and specialized focus can differentiate proposals to cardiology imaging programs and hospital labs. Upsell potential from standalone analysis to full workflow suite across cardiology imaging.

Real Time Analytics FUSION aggregates data from EMRs and other sources to deliver real time views of patient health at the point of care. Target hospital cardio departments, radiology, ER and ICU teams with faster insights, improved workflow efficiency, and better support for clinical decision-making. Opportunity to pair FUSION with HARP for expanded analytics.

Mid Sized Hospitals With a small to mid market footprint, Diagnosoft can focus on regional health systems and imaging centers seeking scalable imaging analytics. Position as a cost efficient, modular solution that can expand across multiple facilities and imaging workflows. Consider channel partnerships to accelerate regional adoption.

Interoperability Opportunity FUSION's data aggregation from EMRs suggests strong demand for seamless integration with enterprise systems. Prioritize partnerships with EMR vendors and integration specialists, highlighting interoperability, data normalization and single pane of glass analytics for clinicians.

Regulatory Advantage Being the developer of the first FDA cleared MR imaging software provides credibility with hospital procurement and audit teams. Build sales narratives around regulatory confidence, clinical validation and reduced risk in implementation.